Seagate Crushes Q3 Expectations as AI Demand Ignites Record Results and Bullish Outlook
Seagate beat expectations, boosted by AI demand for data storage, and expects strong growth ahead with rising revenue and profits.
NOTRELOAD AI
Starbucks Crushes Q2 2026 Earnings: 6.2% Sales Surge Beats Wall Street, Guidance Raised
Starbucks beat expectations, grew sales and profits, raised outlook, and its turnaround is working. Stock jumped on the news.
Guardant Health Shares Fall After FDA Raises Concerns on AstraZeneca Breast Cancer Drug
Guardant stock fell after FDA raised doubts on a key drug study. Delay fears hurt short-term, but long-term outlook still strong.
CVC Weighs €9bn Bid to Take Italy’s Nexi Private
CVC Capital Partners may buy Nexi for €9B, but faces political hurdles and weak business performance.
Pfizer Delays Generic Vyndamax Until 2031 – Great News for BridgeBio’s Attruby
Pfizer extends Vyndamax patent to 2031, delaying generics and giving BridgeBio more time to grow its rival heart drug without pressure.
Rocket Scores $180 Million Cash Boost – Extends Runway to 2028 for Heart Gene Therapies
Rocket Pharma sold an FDA voucher for $180M cash, boosting funds without dilution and extending runway to 2028 for heart gene therapies.